SOC (n = 14) | CCP (n = 17) | |
---|---|---|
Demographics | ||
Age (years)a | 65 (43–84) | 80 (60–86) |
Sex (male)b | 8 (57) | 11 (65) |
BMI (kg/m2)a | 31 (26–35) | 28 (24–34) |
Charlson comorbidity indexa | 1 (0–2) | 1 (0–2) |
Arterial hypertensionb | 6 (42) | 7 (41) |
Factors at inclusion | ||
Symptom duration (days)a | 8 (5–11) | 7 (5–9) |
CRP (mg/L)a | 100 (58–133) | 72 (40–120) |
Lymphocyte count (109/L)a | 0.8 (0.5–1.4) | 0.9 (0.5–1.4) |
Oxygen (L/min)a | 2.5 (1–5) | 2 (1.5–3) |
Patients with SARS-CoV-2 antibodies at inclusiona,c | 2 (18%) | 1 (8%) |
Treatment | ||
Betametasonb | 11 (79) | 11 (65) |
Remdesivirb | 1 (7) | 2 (12) |
Intravenous antibioticsb | 7 (50) | 8 (53) |
Anti-coagulantsb | 14 (100) | 14 (82) |